Navigation Links
Pneumococcal Vaccine: Childhood Immunization Programme has a new recruit

The chief medical officer, Sir Liam Donaldson, has announced the introduction of the routine pneumococcal vaccine into the childhood immunization programme , with a motive to prevent children from falling ill, and thus saving many lives. //

The pneumococcal infection, upon entering the blood stream, can cause health complications, as grave as meningitis, septicemia (blood poisoning) and pneumonia. Almost 50 young lives under age 2 are lost to pneumococcal infections in England and Wales every year. Sir Liam Donaldson said: "Pneumococcal infection can cause very serious illness such as meningitis and pneumonia as well as being one of the most common bacterial causes of ear infections."The under 2s are a particular risk group. The new vaccine will save lives and prevent hundreds more cases of serious illness and disability in both the young and old as well as reducing the need for medical care.'

The US is already witness to the immense benefits of this programme that has brought down the rates of this infection by 94% among young children alone. Sir Liam has additionally introduced changes to the Meningitis C and Hib disease, basically rescheduling the intervals of vaccination to three and four months of age with a booster dose at 12 months. The rescheduling has been done to gain the highest protection possible against the disease. This move follows the latest evidence that suggests decline in the efficacy of the vaccine a year after vaccination, making the child vulnerable to the disease. Children under age 2 are more susceptible to the disease.

Additionally, a booster dose of Hib vaccine is being included in the childhood immunization programme, as a routine at 12 months to extend protection against Hib disease.

Philip Kirby, Chief Executive of the Meningitis Trust said: "Vaccination is the only way to prevent meningitis and we welcome this announcement as it will help save lives. Pneumococcal meningitis is a devas tating disease - 20% of those who get it will die and a further 25% will suffer severe after-effects."

The new vaccines are slated to hit the market in 2006/07. More information on the latest immunization schedule is available at http://www.immunisation.nhs.uk.


'"/>




Related medicine news :

1. Promotion of Pneumococcal Vaccine Slow in Europe
2. Intro of Pneumococcal Vaccines: Experts Urge Commitment From Industry
3. Wyeth Launches Vaccine for Pneumococcal Disease in India
4. March towards Free Pneumococcal Vaccine
5. Immunisation programme to include vaccine against Pneumococcal disease
6. New Vaccine to Combat Pneumococcal Diseases
7. Increase in Pneumococcal Infections That are Not Covered by Vaccine
8. New Bird Flu Virus Resistant To Vaccine: Study
9. Focused Treatment For Childhood Cancer
10. Osteoporosis associated with Childhood Cancer
11. Childhood Sunburn Can Lead to Skin Cancer Later
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... , ... Those who have experienced traumatic events may suffer from a complex ... as drug or alcohol abuse, as a coping mechanism. To avoid this pain and ... a traumatic event. , Trauma sufferers tend to feel a range of emotions, from ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
(Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: